Information Provided By: 
Fly News Breaks for March 8, 2018
SPLK
Mar 8, 2018 | 08:10 EDT
As reported earlier, Argus analyst Joseph Bonner upgraded Splunk to Buy from Neutral with a price target of $120. Bonner says the company is in a fast-growing market, though its success will depend on the execution of a ramp in software sales along with capturing market share without pressure on margins. The analyst is also positive on Splunk's expansion into "adjacent product areas such as IT network security". Bonner adds that the company's valuation is at a 13% discount to the enterprise value to revenue multiple average of its peers.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
